Among the ten pharmacological inhibitors of cyclin-dependent kinases (CDKs) currently in clinical trials, the purine roscovitine (CYC202, Seliciclib) is undergoing phase 2 trials against ...
Forbes contributors publish independent expert analyses and insights. Matthew MacConnell covers the evolving world of motoring. ‘Best EV Crossover’, ‘Car of the Year’, and ‘Best Small Electric SUV’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results